Loading
China Medical System Holdings Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$24.8B
China Medical System Holdings Ltd.: what insiders have been doing
Insider filings for China Medical System Holdings Ltd. are scarce in the HKEX feed, the latest one published on 10 August 2026. This page will fill in as new trades are disclosed. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 4,561 of 23,476 companies
67.2
score / 100
Value56
Quality78
FCF yld1.0%
Earn yld6.0%
EV/EBITDA10.7x
ROE8.4%
Gross mgn71%
Net mgn18%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$10.20
Analyst consensus
9 analysts1.30/5
HK$14.71Target HK$17.70(+73%)HK$20.25
Income statement
RevenueHK$8.2B
Gross profitHK$5.9B71% margin
EBITDAHK$2.4B29% margin
Net incomeHK$1.5B17.6% margin
Valuation
PER (trailing)14.4x
PER (forward)10.5x
P/Book1.2x
Beta1.09
Balance sheet & cash
Market capHK$24.8B
Total debtHK$690.1M
Free Cash FlowHK$244M
Debt / Equity5%
Profitability & ownership
ROE8.4%
ROA5.6%
% insiders48.3%
% institutions25.9%
Last declaration on 10 August 2026
About China Medical System Holdings Ltd.
China Medical System Holdings Ltd. is a company engaged in the research, development, manufacturing, and marketing of pharmaceutical products in China. It primarily focuses on medications for the treatment of chronic diseases and infectious diseases.